| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
| 05/12/2011 | CA2789236A1 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 05/12/2011 | CA2778234A1 Methods and compositions for modulating tau levels |
| 05/12/2011 | CA2774054A1 Nutritional supplements for relief of dry eye |
| 05/11/2011 | EP2319936A2 Yeast screens for agents affecting protein folding |
| 05/11/2011 | EP2319917A2 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/11/2011 | EP2319916A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
| 05/11/2011 | EP2319839A1 Quinazolinone derivatives and their use as CB agonists |
| 05/11/2011 | EP2319585A1 Pharmaceutical products and compositions comprising salmeterol, fluticasone and ipratropium or tiotropium |
| 05/11/2011 | EP2319584A1 Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium |
| 05/11/2011 | EP2319583A1 Pharmaceutical products and compositions comprising salmeterol, budesonide and ipratropium |
| 05/11/2011 | EP2319582A1 Pharmaceutical products and compositions comprising formoterol, budesonide and tiotropium or oxitropium |
| 05/11/2011 | EP2319581A1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 05/11/2011 | EP2319538A2 Combinations combrising antimuscarinic agents and corticosteroids |
| 05/11/2011 | EP2319537A1 Stabilizer for lymph vessel |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319528A2 Methods of increasing platelet and hematopoietic stem cell production |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319518A1 Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| 05/11/2011 | EP2319515A1 Coccidicide combination for veterinary use |
| 05/11/2011 | EP2319508A1 Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| 05/11/2011 | EP2319506A1 Compositions for intratumoral administration |
| 05/11/2011 | EP2319502A1 Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 05/11/2011 | EP2318350A1 ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 muM TO ABOUT 10 muM |
| 05/11/2011 | EP2318049A1 Intranasal compositions comprising a decongestant and a corticosteroid |
| 05/11/2011 | EP2318000A1 Anti-tumoural effects of cannabinoid combinations |
| 05/11/2011 | EP2317998A1 Fulvic acid and antibiotic combination |
| 05/11/2011 | EP2317981A1 Multi-layered lamellar granule and skin external application composition containing same |
| 05/11/2011 | EP1957061B1 Combination comprising at least one amino acid and a pkr inhibitor for use in the treatment of muscle loss |
| 05/11/2011 | EP1718154B1 Canine probiotic lactobacilli |
| 05/11/2011 | CN1989968B Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 05/11/2011 | CN1899614B Preparation for the prophylaxis of restenosis |
| 05/11/2011 | CN1798568B Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
| 05/11/2011 | CN1599623B Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 05/11/2011 | CN102056631A Apoptosis inducer |
| 05/11/2011 | CN102056630A Stabilizer for lymph vessel |
| 05/11/2011 | CN102051016A Degradable amphiphilic triblock copolymer micelle and preparation method and application of degradable amphiphilic triblock copolymer micelle |
| 05/11/2011 | CN102049050A Anti-herpesvirus infection medicinal composition |
| 05/11/2011 | CN102049049A Medical composition containing aspirin salt and stanin medicaments |
| 05/11/2011 | CN102049048A Method of treatment or prophylaxis |
| 05/11/2011 | CN102049047A Drug combination |
| 05/11/2011 | CN102049046A Application of delta opioid receptor antagonist to relief of Alzheimer's disease |
| 05/11/2011 | CN102048697A Method for preparing solid lipid nanoparticles of water-soluble anti-tumor medicine |
| 05/11/2011 | CN102048689A Bioadhesive drug delivery system |
| 05/11/2011 | CN101129405B Biological formulation product for treating habitual abortion |
| 05/10/2011 | US7939650 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | US7939551 for diabetes mellitus and other metabolic disorders; compounds of given formula such as sulfonamides and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists |
| 05/10/2011 | US7939522 Dosage formulations for acetylcholinesterase inhibitors |
| 05/10/2011 | US7939292 Modified heparinase III and methods of sequencing therewith |
| 05/10/2011 | US7939118 Oligosaccharide mixture |
| 05/10/2011 | US7939098 Compositions and method for transmucosal drug delivery and cryoprotection |
| 05/10/2011 | US7939090 System and method for the treatment of cancer, including cancers of the central nervous system |
| 05/10/2011 | US7939086 Modified Vaccinia Ankara virus variant |
| 05/10/2011 | US7939085 Attenuated myxomavirus that has lost receptor properties of myxomavirus interferon receptor or myxomavirus tumor necrosis factor receptor or myxomavirus interleukin receptor; causes an increase in number of leukocytes in human patient 7 days after administration |
| 05/10/2011 | US7939074 Combination of an anti-EP-CAM antibody with a chemotherapeutic agent |
| 05/10/2011 | US7939071 Artery- and vein-specific proteins and uses therefor |
| 05/10/2011 | US7939058 Interleukin-12 (IL-12) used after chemotherapy, radiotherapy or viral infection to yield hematopoietic recovery, for bone marrow preservation or recovery |
| 05/10/2011 | CA2622805C Compressed tablets comprising valsartan |
| 05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
| 05/10/2011 | CA2480033C In vivo use of glutathionone s-transferase activated nitric oxide donors |
| 05/10/2011 | CA2451279C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| 05/10/2011 | CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/10/2011 | CA2423524C Topical anti-cancer compositions and methods of use thereof |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/10/2011 | CA2382560C Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 05/10/2011 | CA2377373C Nitric oxide donors for inducing neurogenesis |
| 05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
| 05/05/2011 | WO2011052750A1 Anticancer agent sensitivity-determining marker |
| 05/05/2011 | WO2011052749A1 Method for determination of sensitivity to anti-cancer agent |
| 05/05/2011 | WO2011052748A1 Method for determining sensitivity to an anticancer agent |
| 05/05/2011 | WO2011052628A1 Angiogenesis promoter |
| 05/05/2011 | WO2011051894A1 Novel antitumoral use of cabazitaxel |
| 05/05/2011 | US20110107442 Treatment of Male Sexual Dysfunction |
| 05/05/2011 | US20110106193 Cardiac disease treatment and device |
| 05/05/2011 | US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 05/05/2011 | US20110105620 Organic compounds |
| 05/05/2011 | US20110105557 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 05/05/2011 | US20110105551 Analgesics for nasal administration |
| 05/05/2011 | US20110105519 Pharmaceutical Compositions for the Treatment of Sexual Disorders II |
| 05/05/2011 | US20110105452 Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance |
| 05/05/2011 | US20110104304 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 05/05/2011 | US20110104251 Cosmetic Composition And Method For Retarding Hair Growth |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104128 Device and Method for Transfecting Cells for Therapeutic Use |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | US20110100361 Pressurised metered dose inhalers (mdi) |
| 05/05/2011 | DE102009044375A1 Use of a compound, preferably an inhibitor of aldosterone synthase comprising e.g. 4-androstene-4-ol-3,17-dione or 4-androstene-3,17-dione, for the treatment and/or prevention of hyperaldosteronism and/or cardiovascular disease |
| 05/05/2011 | DE102009027754A1 Verfahren zur Hemmung der Reifung von dendritischen Zellen A method of inhibiting the maturation of dendritic cells |
| 05/05/2011 | CA2779009A1 Novel antitumoral use of cabazitaxel |
| 05/04/2011 | EP2316976A1 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 05/04/2011 | EP2316924A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316923A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316488A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/04/2011 | EP2316470A2 Peptidomimetic inhibitors of post-proline cleaving enzymes |